PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
71.77
+4.05 (5.98%)
At close: Nov 5, 2025, 4:00 PM EST
71.40
-0.37 (-0.52%)
Pre-market: Nov 6, 2025, 6:25 AM EST
PTC Therapeutics (PTCT) Revenue by Product
History
| Date | Translarna | Emflaza |
|---|---|---|
| Jun 30, 2025 | 311.80M | 186.30M |
| Mar 31, 2025 | 322.70M | 197.20M |
| Dec 31, 2024 | 340.30M | 206.70M |
| Sep 30, 2024 | 321.50M | 224.10M |
| Jun 30, 2024 | 318.20M | 239.60M |
| Mar 31, 2024 | 344.30M | 258.00M |
| Dec 31, 2023 | 355.80M | 255.10M |
| Sep 30, 2023 | 336.40M | 245.80M |
| Jun 30, 2023 | 344.00M | 233.20M |
| Mar 31, 2023 | 324.50M | 224.30M |
| Dec 31, 2022 | 288.60M | 218.30M |
| Sep 30, 2022 | 302.50M | 207.70M |
| Jun 30, 2022 | 293.10M | 200.00M |
| Mar 31, 2022 | 268.70M | 192.30M |
| Dec 31, 2021 | 236.00M | 187.20M |
| Sep 30, 2021 | 235.70M | 176.50M |
| Jun 30, 2021 | 211.90M | 167.90M |
| Mar 31, 2021 | 197.90M | 155.00M |
| Dec 31, 2020 | 191.90M | 139.00M |
Source: Business metrics provided by Main Street Data and sourced
from official company press releases and documents.